Antiviral prophylaxis is essential for HBsAg+ patients receiving cytokine inhibitors, given the high risk of reactivation. Metanalysis of 10 studies shows reactivation in 21% of HBsAg+ patients without prophylaxis vs 4.4% in HBsAg−/HBcAb+ patients. https://t.co/eHzIeA8uJK https://t.co/CmZw8C8ibn
Links:
Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibit…
https://buff.ly/3DEJqSN
Jan-03-2025
